1.30 0.00 (0.00%)

70.45% Fall from 52W High

179 XNAS Volume

XNAS 28 Mar, 2025 12:41 PM (EDT)

Board Meeting
The next board meeting for Akari Therapeutics Plc - ADR is on 01 Apr 2025 for the purpose of Akari Therapeutics PLC Fourth Quarter Earnings Results for 2024 See details


Insider Trading disclosures for Akari Therapeutics Plc - ADR

The latest disclosure was made by Abizer Gaslightwala in Akari Therapeutics Plc - ADR where a trade of 600,000 Stock Option (Right to Buy) done was reported to US exchanges on March 20, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Abizer Gaslightwala Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Mar 2025 600,000 600,000 - - Stock Option (Right to Buy)
Hoyoung Huh Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Mar 2025 225,000 225,000 - - Stock Option (Right to Buy)
Hoyoung Huh Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Mar 2025 175,000 175,000 - - Stock Option (Right to Buy)
Torsten Hombeck CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Mar 2025 200,000 200,000 - - Stock Option (Right to Buy)
Torsten Hombeck CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Mar 2025 300,000 300,000 - - Stock Option (Right to Buy)
James R. Neal Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Mar 2025 225,000 225,000 - - Stock Option (Right to Buy)
James R. Neal Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Mar 2025 175,000 175,000 - - Stock Option (Right to Buy)
Robert B. Bazemore Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Mar 2025 225,000 225,000 - - Stock Option (Right to Buy)
Robert B. Bazemore Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Mar 2025 175,000 175,000 - - Stock Option (Right to Buy)
Raymond Prudo-Chlebosz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Mar 2025 225,000 225,000 - - Stock Option (Right to Buy)
Raymond Prudo-Chlebosz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Mar 2025 175,000 175,000 - - Stock Option (Right to Buy)
Sandip I. Patel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Mar 2025 225,000 225,000 - - Stock Option (Right to Buy)
Sandip I. Patel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Mar 2025 175,000 175,000 - - Stock Option (Right to Buy)
Samir Rashmikant Patel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Mar 2025 175,000 175,000 - - Stock Option (Right to Buy)
Samir Rashmikant Patel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Mar 2025 225,000 225,000 - - Stock Option (Right to Buy)
Abizer Gaslightwala Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Mar 2025 1,100,000 1,100,000 - - Stock Option (Right to Buy)
Hoyoung Huh Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2025 892,857 892,857 - - Series A Warrants (Right to Buy)
Hoyoung Huh Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2025 892,857 892,857 - - Series B Warrants (Right to Buy)
Hoyoung Huh Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 1.12 per share. 06 Mar 2025 892,857 4,695,854 (0%) 0% 1.1 1,000,000 American Depositary Shares representing Ordinary Shares
James R. Neal Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2025 4,464 4,464 - - Series B Warrants (Right to Buy)
James R. Neal Director Grant, award, or other acquisition of securities at price $ 1.12 per share. 06 Mar 2025 4,464 36,271 (0%) 0% 1.1 5,000 American Depositary Shares representing Ordinary Shares
James R. Neal Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2025 4,464 4,464 - - Series A Warrants (Right to Buy)
Robert B. Bazemore Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2025 44,642 44,642 - - Series A Warrants (Right to Buy)
Robert B. Bazemore Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2025 44,642 44,642 - - Series B Warrants (Right to Buy)
Robert B. Bazemore Director Grant, award, or other acquisition of securities at price $ 1.12 per share. 06 Mar 2025 44,642 44,642 (0%) 0% 1.1 49,999 American Depositary Shares representing Ordinary Shares
Raymond Prudo-Chlebosz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2025 446,428 446,428 - - Series A Warrants (Right to Buy)
Raymond Prudo-Chlebosz Director Grant, award, or other acquisition of securities at price $ 1.12 per share. 06 Mar 2025 446,428 2,484,990 (0%) 0% 1.1 499,999 American Depositary Shares representing Ordinary Shares
Raymond Prudo-Chlebosz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2025 446,428 446,428 - - Series B Warrants (Right to Buy)
Samir Rashmikant Patel Director Grant, award, or other acquisition of securities at price $ 1.12 per share. 06 Mar 2025 406,250 3,031,005 (0%) 0% 1.1 455,000 American Depositary Shares representing Ordinary Shares
Samir Rashmikant Patel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2025 406,250 406,250 - - Series A Warrants (Right to Buy)
Samir Rashmikant Patel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2025 406,250 406,250 - - Series B Warrants (Right to Buy)
Abizer Gaslightwala Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2025 133,928 133,928 - - Series A Warrants (Right to Buy)
Abizer Gaslightwala Director Grant, award, or other acquisition of securities at price $ 1.12 per share. 06 Mar 2025 133,928 181,428 (0%) 0% 1.1 149,999 American Depositary Shares representing Ordinary Shares
Abizer Gaslightwala Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2025 133,928 133,928 - - Series B Warrants (Right to Buy)
Abizer Gaslightwala Director Grant, award, or other acquisition of securities at price $ 1.22 per share. 10 Jan 2025 11,640 47,500 (0%) 0% 1.2 14,201 American Depository Shares representing Ordinary Shares
Abizer Gaslightwala Director Grant, award, or other acquisition of securities at price $ 1.22 per share. 10 Jan 2025 11,439 35,860 (0%) 0% 1.2 13,956 American Depository Shares representing Ordinary Shares
Torsten Hombeck CFO Grant, award, or other acquisition of securities at price $ 1.22 per share. 10 Jan 2025 200 200 (0%) 0% 1.2 244 American Depository Shares representing Ordinary Shares
Abizer Gaslightwala Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2025 1,720,000 71,720,000 (4%) 0% 0.0 1,032 Ordinary Shares, par value $0.0001 per share
Samir Rashmikant Patel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2025 152,672,000 152,672,000 - - Stock Option (Right to Buy)
Samir Rashmikant Patel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2025 208,000 5,249,511,500 (344%) 0% 0.0 125 Ordinary Shares, par value $0.0001 per share
Gaslightwala Abizer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Dec 2024 40,000,000 70,000,000 (4%) 2% 0.0 20,000 Ordinary Shares, par value $0.0001 per share
Gaslightwala Abizer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Dec 2024 30,000,000 30,000,000 (1%) 1% 0.0 15,000 Ordinary Shares, par value $0.0001 per share
Rashmikant Patel Samir Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Dec 2024 400,000 5,249,303,500 (344%) 0% 0.0 200 Ordinary Shares, par value $0.0001 per share
Rashmikant Patel Samir Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Dec 2024 3,200,000 5,248,903,500 (344%) 0% 0.0 1,600 Ordinary Shares, par value $0.0001 per share
Samir Patel Rashmikant Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Dec 2024 7,500,000 5,245,703,500 (343%) 0% 0.0 3,750 Ordinary Shares, par value $0.0001 per share
R. James Neal Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2024 2,000,000 24,216,000 (1%) 0% 0.0 1,000 Ordinary Shares, par value $0.0001 per share
Samir Patel Rashmikant Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2024 1,400,000 5,238,203,500 (343%) 0% 0.0 700 Ordinary Shares, par value $0.0001 per share
Rashmikant Patel Samir Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Dec 2024 1,400,000 5,236,803,500 (343%) 0% 0.0 700 Ordinary Shares, par value $0.0001 per share
Prudo-Chlebosz Raymond Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Dec 2024 419,286,000 419,286,000 - - Warrants (Right to Buy)
Raymond Prudo-Chlebosz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Dec 2024 419,286,000 4,077,124,600 (267%) 27% 0.0 503,143 Ordinary Shares, par value $0.0001 per share
Patel Samir Rashmikant Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Nov 2024 419,286,000 5,235,403,500 (343%) 27% 0.0 503,143 Ordinary Shares, par value $0.0001 per share
Patel Samir Rashmikant Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Nov 2024 419,286,000 419,286,000 - - Warrants (Right to Buy)
Samir Rashmikant Patel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Nov 2024 162,604,000 162,604,000 - - Stock Option (Right to Buy)
Samir Rashmikant Patel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Nov 2024 1,404,622,000 4,816,117,500 (315%) 92% - Ordinary Shares, par value $0.0001 per share
Samir Rashmikant Patel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Oct 2024 79,684,000 79,684,000 - - Stock Option (Right to Buy)
Samir Rashmikant Patel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2024 175,080,000 175,080,000 - - Stock Option (Right to Buy)
Robert B. Bazemore Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Sep 2024 5,000,000 5,000,000 - - Stock Option (Right to Buy)
Samir Rashmikant Patel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2024 91,396,000 91,396,000 (5%) 5% 0 Ordinary Shares, par value $0.0001 per share
Michael Grissinger Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jun 2024 5,000,000 5,000,000 - - Stock Option (Right to Buy)
Mohamed Wael Ahmed Hashad Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jun 2024 5,000,000 5,000,000 - - Stock Option (Right to Buy)
Raymond Prudo-Chlebosz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jun 2024 10,000,000 10,000,000 - - Stock Option (Right to Buy)
Samir Rashmikant Patel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 May 2024 1,326,258,000 3,411,495,500 (223%) 86% 0.0 1,193,632 Ordinary Shares, par value $0.0001 per share
Samir Rashmikant Patel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 May 2024 1,326,258,000 1,326,258,000 - - Warrants (Right to Buy)
Raymond Prudo-Chlebosz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 May 2024 1,326,258,000 1,326,258,000 - - Warrants (Right to Buy)
Raymond Prudo-Chlebosz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 May 2024 1,326,258,000 3,657,838,600 (239%) 86% 0.0 1,193,632 Ordinary Shares, par value $0.0001 per share
Wendy F. DiCicco Interim CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 May 2024 158,473,915 158,473,915 (10%) 10% 0 Ordinary Shares, par value $0.0001 per share
Rachelle S. Jacques Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Apr 2024 479,569,892 1,018,027,792 (66%) 31% 0 Ordinary Shares, par value $0.0001 per share
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures